Novo Nordisk Shares Jump 3% After Withdrawing from $10 Billion Metsera Bidding War

Novo Nordisk stock climbed up to 3% after the Danish drugmaker withdrew from its heated bidding war with Pfizer over obesity drug startup Metsera, citing financial discipline concerns.